Sargent Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Sargent Investment Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$371K	Sell	740 -29	-4%	-$13.9K	0.04%	191
2026 Q1	$378K	Buy	769 +14	+2%	+$7.6K	0.05%	182
2025 Q4	$437K	Buy	+755	New	+$427K	0.05%	170
2025 Q3	–	Sell	-724	Closed	-$325K	–	218
2025 Q2	$325K	Sell	724 -403	-36%	-$168K	0.04%	185
2025 Q1	$561K	Buy	1,127 +416	+59%	+$225K	0.09%	137
2024 Q4	$395K	Buy	711 +47	+7%	+$25.8K	0.06%	159
2024 Q3	$411K	Buy	664 +4	+0.6%	+$2.37K	0.07%	136
2024 Q2	$365K	Sell	660 -17	-3%	-$9.74K	0.07%	142
2024 Q1	$393K	Sell	677 -194	-22%	-$109K	0.09%	131
2023 Q4	$462K	Buy	871 +201	+30%	+$97.3K	0.1%	130
2023 Q3	$339K	Buy	+670	New	+$357K	0.08%	146

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sargent Investment Group's TMO Position: Q2 2026 in Review

Sargent Investment Group reduced its Thermo Fisher Scientific (TMO) stake by 3.8% in Q2 2026, selling an estimated $13.9K and leaving 740 shares worth $371K. The position accounts for 0.04% of the portfolio, ranked #191.

Sargent Investment Group first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $561K in Q1 2025. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Sargent Investment Group held 740 shares of Thermo Fisher Scientific worth $371K as of Q2 2026.
Sargent Investment Group sold 29 Thermo Fisher Scientific shares in Q2 2026, an estimated $13.9K.
Thermo Fisher Scientific made up 0.04% of Sargent Investment Group's portfolio in Q2 2026, its #191 holding.
Sargent Investment Group first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
Sargent Investment Group's Thermo Fisher Scientific position peaked at $561K in Q1 2025.
2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.